概括
印度制药档案揭示了从药物安全向药物安全的转变,在这种情况下,纸张工作,而不是化学成分,决定了药物的质量和真实性. 这凸显了监管文档如何影响市场观念和国际贸易.
科学领域:
- 药品监管法规 药品监管法规 药品监管法规
- 科学的社会学科学社会学.
- 全球商业 全球商业
背景情况:
- 制药行业依赖监管标准来确保药物的质量和安全.
- 全球正在从对药物安全的关注转向对药物安全的关注.
- 印度制药档案是证明监管合规性的关键文件.
研究的目的:
- 检查印度制药档案如何说明从药物安全到药物安全的转变.
- 分析档案文件如何产生关于药品质量和真实性的说法.
- 质疑传统的监管概念"假冒",优先考虑化学成分.
主要方法:
- 印度制药档案的分析.
- 与印度交易员和监管官员的采访.
- 检查监管工作的变化随着时间的推移.
主要成果:
- 药品质量和真实性越来越多地通过档案文件工作来产生,而不是仅仅通过化学成分.
- 转向药物安全的转变使得在许多情况下,文书工作比药品本身更为重要.
- 这种监管转变影响着整个制药市场和国际贸易条件.
结论:
- 通过档案颁布的重点是药物安全,这代表了制药监管的重大变化.
- 药品中"假冒性"的概念被重新定义,超越化学分析,涵盖监管文档.
- 药物安全文档塑造了全球制药商业和对药物真实性的看法.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Distribution: Volume of Distribution
5.0K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
5.0K
Pharmacovigilance
829
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
829
Volume of Distribution
172
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
172
Drug Distribution: Overview
180
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
180
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K


